Tuberculosis Vaccine Market Size, Share, Analysis, Growth and Future Forecast - 2031

The global tuberculosis vaccine market is anticipated to grow at a CAGR of 8.4% during the forecast period. Tuberculosis vaccine such as BCG (stands for Bacille Calmette-Guérin) is the most widely used tuberculosis vaccine and are being commercialized for the prevention of tuberculosis. Various advancements in the areas of mycobacterial immunology and genomics have fueled the research on multiple new experimental vaccines that is the key factor driving the market growth. In addition to this, the relatively low cost of these vaccines, as well as the easy availability of the vaccine are the major drivers of the industry growth. With an increase in the number of tuberculosis cases globally, the demand for tuberculosis vaccines is projected to increase more, thereby driving the market growth. As per WHO, a total of 1.5 million people died from TB in 2020 (including 214 000 people with HIV). In the same year, 1.1 million children fell ill with TB globally. TB is the 13th leading cause of death and the second leading infectious killer after COVID-19. 

Get Free Sample link @ https://www.omrglobal.com/request-sample/tuberculosis-vaccine-market

Moreover, the growth in the technological advancements for vaccine research, rising government initiatives, and emphasis on immunization programs all over the globe will also boost the market growth during the forecast period. However, the side effect such as high temperature, headache, swollen glands under the armpit, and soreness or discharge where the injection was given, associated with the vaccine may act as restrain the further growth of the market. 

Full report of Tuberculosis Vaccine Market available @ https://www.omrglobal.com/industry-reports/tuberculosis-vaccine-market

Segmental Outlook  

The global tuberculosis vaccine market is segmented based on type and application. Based on type, the market is bifurcated into immunotherapeutic vaccines and booster vaccines. Among these, the immunotherapeutic vaccine segment is going to dominate by accounting highest share and is also expected to be the fastest-growing during the forecast period. Immunotherapeutic vaccine such as Bacille Calmette-Guérin (BCG) is prescribed for tuberculosis disease prevention. It provides consistent protection against the most severe forms of TB, such as TB meningitis in children. An increase in the number of newborn babies and the prevalence of pediatric tuberculosis is likely to drive segment expansion. As per CDC, in 2020, there were 317 cases of TB disease among children ages 14 years or younger in the US, accounting for 4% of all people reported with TB nationally. Based on application, the market is further sub-categorized into hospitals, clinics, and others. 

Regional Outlook 

Geographically, the global tuberculosis vaccine market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). The Europe region is likely to hold considerable market share during the forecast period owing to the rapid increase in the number of tuberculosis cases that are generating product demand. As per the European Centre for Disease Prevention and Control, in  2019, 49 752 cases of TB were reported in 29 European Union and European Economic Area (EU/EEA) countries, resulting in a notification rate of 9.6 per 100,000 population in the EU/EEA. 

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tuberculosis-vaccine-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Article source: https://article-realm.com/article/Business/70631-Tuberculosis-Vaccine-Market-Size-Share-Analysis-Growth-and-Future-Forecast-2031.html